Biotechnology | FDA | Oncology | Therapeutics
FDA approves first cancer drug based on Broad Institute science
On Nov. 20, 2025, the US Food and Drug Administration (FDA) has approved the first cancer drug based…
Biotechnology | Cardiology | Clinical Research | CRISPR | Disease | FDA | Genomics | HIV | Infectious Disease | Influenza | Nanotechnology | Neurology | NIH | Oncology | Organ Transplant | Rare Disease | Stem Cell | Therapeutics | U.S. Congress | Vaccine | Women's Health
Halted NIH Clinical Trials List Reveals Slashed Treatments for Cancer, COVID and Minority Health
On Nov. 20, 2025, the National Institutes of Health (NIH) has canceled funding for at least 383 clinical…
CPRIT approves $154 million in new cancer research and prevention awards, surpasses $4 billion total
On Nov. 19, 2025, the governing board of the Cancer Prevention and Research Institute of Texas (CPRIT) approved…
Novartis announces plans to build flagship manufacturing hub in North Carolina
On Nov. 19, 2025, Novartis, a leading global innovative medicines company, announced plans to expand its operations in…
CSL injects $2.3b into US for valuable blood plasma
On Nov. 18, 2025, CSL, Australia’s largest biotech company announced plans to expand its US presence with a…
Type 1 diabetes cured in mice with gentle blood stem-cell and pancreatic islet transplant
On Nov. 18, 2025, Stanford Medicine researchers reported that a combination blood stem cell and pancreatic islet cell…
Johnson & Johnson to acquire Halda Therapeutics for $3.05 billion, revolutionize treatment of cancer
On Nov. 17, 2025, Johnson & Johnson announced that it has entered into a definitive agreement to acquire…
Biotechnology | Disease | FDA | Therapeutics
Sandoz launches TYRUKO® (natalizumab-sztn) in US, as first and only multiple sclerosis biosimilar
On Nov. 17, 2025, Sandoz announced that TYRUKO® (natalizumab-sztn) is available to patients in the US. Developed by…
CRISPR breakthrough reverses chemotherapy resistance in lung cancer
On Nov. 17, 2025,In a major step forward for cancer care, researchers at ChristianaCare’s Gene Editing Institute have…
Agriculture | Artificial Intelligence | Biotechnology | Chemistry | Clinical Research | Diagnostics | Energy | Environmental | Infectious Disease | Marine Science | Medical Device | Nanotechnology | Neurology | NIH | Non-Profit Research | Rare Disease | Therapeutics | Vaccine | Women's Health
NIH funding cuts have impacted more than 74,000 people enrolled in trials
On Nov. 17, 2025, a JAMA published study found that more than 74,000 people have had their lives…
Merck to Acquire Cidara Therapeutics for $9.2 Billion, Diversifying Its Portfolio to Include Late-Phase Antiviral Agent
On Nov. 14, 2025, Merck and Cidara Therapeutics, a biotechnology company developing drug-Fc conjugate (DFC) therapeutics, announced that…
Ethiopia reports suspected viral haemorrhagic fever outbreak
On Nov. 13, 2025, the World Health Organization (WHO) reported that Health authorities in Ethiopia are carrying out…
FDA Quietly Approves Denosumab Biosimilars, Issues Interchangeability for Others
On Nov. 13, 2025, the U.S. Food and Drug Administration (FDA) approved multiple denosumab biosimilars, enhancing market access…
Scientists unveil the world’s most comprehensive AI-powered tool for neuroscience: Brain Knowledge Platform
On Nov. 12, 2025, Allen Institute researchers and engineers have unlocked an the world’s most comprehensive AI-powered tool…
Biotechnology | Diagnostics | Infectious Disease | Non-Profit Research | Therapeutics | Vaccine | Women's Health
Stanford Medicine scientists tie lupus to a virus nearly all of us carry
On Nov. 12, 2025, Stanford Medicine scientists have found that the Epstein-Barr virus can convert B cells it’s…
Pfizer to Acquire Metsera and its Next-Generation Obesity Portfolio for $4.9 billion
On Nov. 11, 2025, Pfizer and Metsera announced the companies have entered into a definitive agreement under which…
Animal testing to be phased out faster as UK unveils roadmap for alternative methods
On Nov. 11, 2025, the United Kingdom government announced that animal testing in science is set to be…
Artificial Intelligence | Biotechnology | Energy | Environmental | Forestry | Genomics | Infectious Disease | Nanotechnology | Neurology | Oncology | Pharmaceutical | Therapeutics | Vaccine
China’s new scientist visa is a ‘serious bid’ for the world’s top talent
On Nov. 11, 2025, China introduced a visa that will allow young foreign researchers in science, technology, engineering…
Existing evidence does not clearly link paracetamol use during pregnancy with autism or ADHD in children
On Nov. 10, 2025, a study led by the University of Liverpool reported that existing evidence does not…
Despite global decrease, Chagas disease is rising in non-endemic regions
On Nov. 6, 2025, the Institute for Health Metrics and Evaluation (IHME) at the University of Washington School…
WHO publishes new global research agenda to strengthen paediatric clinical trials
On Nov. 6, 2025, the World Health Organization (WHO) released a technical report, The future of paediatric clinical trials…
Biotechnology | FDA | Medicine | Therapeutics
Lilly and U.S. government agree to expand access to obesity medicines to millions of Americans
On Nov. 6, 2025, Eli Lilly announced an agreement with the U.S. government to expand access to its…
Oxford scientists capture genome’s structure in unprecedented detail
On Nov. 6, 2025, scientists from Oxford’s Radcliffe Department of Medicine have achieved the most detailed view yet…
Novo Nordisk announces agreement with the U.S. Administration to bring GLP-1s to more Americans at a lower cost
On Nov. 6, 2025, Novo Nordisk announced it has agreed with the U.S. Administration to lower drug prices…
Biotechnology | Disease | FDA | Therapeutics
FDA approves menin inhibitor for patients with acute leukemia with NPM1 mutation, backed by Dana-Farber science
On Nov. 4, 2025, the U.S. Food and Drug Administration (FDA) approved revumenib, a first-in-class oral menin inhibitor,…
CIRM awards $27 million to launch novel program designed to bring cell and gene therapies to underserved California communities
On Oct. 30, 2025, the California Institute for Regenerative Medicine (CIRM) approved awarding $27 million through three grants…
Thermo Fisher to buy clinical services provider Clario for up to $9.4 billion
On Oct. 29, 2025, Thermo Fisher announced it would buy privately held data management company Clario for up…
Phage G genome: AI analysis maps out world’s largest cultivated bacteria-killing virus
On Oct. 29, 2025, University of North Carolina at Charlotte (UNC) researchers leading a multidisciplinary team across four…
Rice launches Brain Institute to accelerate discoveries in brain science and health
On Oct. 29, 2025, Rice University announced the creation of the Rice Brain Institute (RBI), an ambitious, interdisciplinary…
Lilly partners with Nvidia on AI supercomputer to speed up drug development
On Oct. 28, 2025, Eli Lilly said on Tuesday it was collaborating with Nvidia to build a supercomputer…